77 related articles for article (PubMed ID: 20853307)
1. Modeling and predicting interactions between the human amphiphysin SH3 domains and their peptide ligands based on amino acid information.
Cai J; Ou R; Xu YS; Yang L; Lin Z; Shu M
J Pept Sci; 2010 Nov; 16(11):627-32. PubMed ID: 20853307
[TBL] [Abstract][Full Text] [Related]
2. Factor analysis scales of generalized amino acid information as applied in predicting interactions between the human amphiphysin-1 SH3 domains and their peptide ligands.
Liang G; Chen G; Niu W; Li Z
Chem Biol Drug Des; 2008 Apr; 71(4):345-51. PubMed ID: 18318694
[TBL] [Abstract][Full Text] [Related]
3. Modeling and prediction of binding affinities between the human amphiphysin SH3 domain and its peptide ligands using genetic algorithm-Gaussian processes.
Zhou P; Tian F; Chen X; Shang Z
Biopolymers; 2008; 90(6):792-802. PubMed ID: 18814309
[TBL] [Abstract][Full Text] [Related]
4. Prediction of binding affinities between the human amphiphysin-1 SH3 domain and its peptide ligands using homology modeling, molecular dynamics and molecular field analysis.
Hou T; McLaughlin W; Lu B; Chen K; Wang W
J Proteome Res; 2006 Jan; 5(1):32-43. PubMed ID: 16396493
[TBL] [Abstract][Full Text] [Related]
5. Toward quantitative characterization of the binding profile between the human amphiphysin-1 SH3 domain and its peptide ligands.
He P; Wu W; Wang HD; Yang K; Liao KL; Zhang W
Amino Acids; 2010 Apr; 38(4):1209-18. PubMed ID: 19669081
[TBL] [Abstract][Full Text] [Related]
6. Exploring the activity space of peptides binding to diverse SH3 domains using principal property descriptors derived from amino acid rotamers.
He P; Wu W; Yang K; Jing T; Liao KL; Zhang W; Wang HD; Hua X
Biopolymers; 2011; 96(3):288-301. PubMed ID: 20690173
[TBL] [Abstract][Full Text] [Related]
7. Characterization of domain-peptide interaction interface: a case study on the amphiphysin-1 SH3 domain.
Hou T; Zhang W; Case DA; Wang W
J Mol Biol; 2008 Feb; 376(4):1201-14. PubMed ID: 18206907
[TBL] [Abstract][Full Text] [Related]
8. In silico quantitative prediction of peptides binding affinity to human MHC molecule: an intuitive quantitative structure-activity relationship approach.
Tian F; Yang L; Lv F; Yang Q; Zhou P
Amino Acids; 2009 Mar; 36(3):535-54. PubMed ID: 18575802
[TBL] [Abstract][Full Text] [Related]
9. Applying chemometrics approaches to model and predict the binding affinities between the human amphiphysin SH3 domain and its peptide ligands.
Liu L; He D; Yang S; Xu Y
Protein Pept Lett; 2010 Feb; 17(2):246-53. PubMed ID: 20214647
[TBL] [Abstract][Full Text] [Related]
10. Crystal structure of the abl-SH3 domain complexed with a designed high-affinity peptide ligand: implications for SH3-ligand interactions.
Pisabarro MT; Serrano L; Wilmanns M
J Mol Biol; 1998 Aug; 281(3):513-21. PubMed ID: 9698566
[TBL] [Abstract][Full Text] [Related]
11. The identification of conserved interactions within the SH3 domain by alignment of sequences and structures.
Larson SM; Davidson AR
Protein Sci; 2000 Nov; 9(11):2170-80. PubMed ID: 11152127
[TBL] [Abstract][Full Text] [Related]
12. SH3-SPOT: an algorithm to predict preferred ligands to different members of the SH3 gene family.
Brannetti B; Via A; Cestra G; Cesareni G; Helmer-Citterich M
J Mol Biol; 2000 Apr; 298(2):313-28. PubMed ID: 10764600
[TBL] [Abstract][Full Text] [Related]
13. Structure-based prediction of the Saccharomyces cerevisiae SH3-ligand interactions.
Fernandez-Ballester G; Beltrao P; Gonzalez JM; Song YH; Wilmanns M; Valencia A; Serrano L
J Mol Biol; 2009 May; 388(4):902-16. PubMed ID: 19324052
[TBL] [Abstract][Full Text] [Related]
14. Binding of the proline-rich segment of myelin basic protein to SH3 domains: spectroscopic, microarray, and modeling studies of ligand conformation and effects of posttranslational modifications.
Polverini E; Rangaraj G; Libich DS; Boggs JM; Harauz G
Biochemistry; 2008 Jan; 47(1):267-82. PubMed ID: 18067320
[TBL] [Abstract][Full Text] [Related]
15. Predicting the binding affinity of epitope-peptides with HLA-A*0201 by encoding atom-pair non-covalent interaction information between receptor and ligands.
Hu L; Ai Z; Liu P; Xiong Q; Min M; Lan C; Wang J; Fan L; Chen D
Chem Biol Drug Des; 2010 Jun; 75(6):597-606. PubMed ID: 20565476
[TBL] [Abstract][Full Text] [Related]
16. SH3 domains and drug design: ligands, structure, and biological function.
Dalgarno DC; Botfield MC; Rickles RJ
Biopolymers; 1997; 43(5):383-400. PubMed ID: 9566119
[TBL] [Abstract][Full Text] [Related]
17. Analysis of peptide-protein binding using amino acid descriptors: prediction and experimental verification for human histocompatibility complex HLA-A0201.
Guan P; Doytchinova IA; Walshe VA; Borrow P; Flower DR
J Med Chem; 2005 Nov; 48(23):7418-25. PubMed ID: 16279801
[TBL] [Abstract][Full Text] [Related]
18. Ligand-induced strain in hydrogen bonds of the c-Src SH3 domain detected by NMR.
Cordier F; Wang C; Grzesiek S; Nicholson LK
J Mol Biol; 2000 Dec; 304(4):497-505. PubMed ID: 11099375
[TBL] [Abstract][Full Text] [Related]
19. A set of new amino acid descriptors applied in prediction of MHC class I binding peptides.
Liang G; Yang L; Chen Z; Mei H; Shu M; Li Z
Eur J Med Chem; 2009 Mar; 44(3):1144-54. PubMed ID: 18662841
[TBL] [Abstract][Full Text] [Related]
20. Solution structure of the Grb2 N-terminal SH3 domain complexed with a ten-residue peptide derived from SOS: direct refinement against NOEs, J-couplings and 1H and 13C chemical shifts.
Wittekind M; Mapelli C; Lee V; Goldfarb V; Friedrichs MS; Meyers CA; Mueller L
J Mol Biol; 1997 Apr; 267(4):933-52. PubMed ID: 9135122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
